Molecular pathology exists within a rapidly changing environment. The Strategic Opportunities Committee asseses the opportunities and challenges in the molecular pathology profession and other environments external to the organization that affect AMP interests.
The Strategic Opportunities Committee carries out the activities listed below and provides relevant reports and recommendations to the Board of Directors:
If you are interested in serving on the Strategic Opportunities Committee, please see the various roles available and the responsibilities of each role by clicking here.
Chair
Yassmine M.N. Akkari, Ph.D.
Nationwide Children’s Hospital/
The Ohio State University College of Medicine
Board Members
Alanna Church, M.D.
Boston Children's Hospital
Jonathan Nowak, M.D. Ph.D.
Brigham and Women's Hospital
Members
Federico A. Monzon, M.D.
Genomic Path
Nirali M. Patel, M.D.
Tempus Labs
Michael Hadjisavas, B.S.
GreyBird Ventures
Ester Stein, M.S.
Abbott
Adviser
Anthony N. Sireci, M.D., M.S.
Loxo–Lilly
President
Aaron D. Bossler, M.D., Ph.D.
H. Lee Moffitt Cancer Center and Research Institute
Chief Executive Officer
Laurie S. Menser, CAE